Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Until today this year the stock’s price performance recorded an increase of 8.35%. However, over the last six months, the performance has been stronger by -4.60%. The price of TNYA increased 80.96% over the last 30 days. And in the last five days, it has surged by 18.60%.
Tenaya Therapeutics Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $7.01 on 03/05/24, while the lowest price for the same period was registered at $1.61 on 10/10/24.
52-week price history of TNYA Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Tenaya Therapeutics Inc’s current trading price is -49.92% away from its 52-week high, while its distance from the 52-week low is 118.06%. The stock’s price range during this period has varied between$1.61 and $7.01. The Tenaya Therapeutics Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.35 million for the day, a figure considerably lower than their average daily volume of 2.61 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Tenaya Therapeutics Inc (TNYA) has experienced a quarterly rise of 43.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 278.12M and boasts a workforce of 140 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.51, with a change in price of unch. Similarly, Tenaya Therapeutics Inc recorded 1,809,411 in trading volume during the last 100 days, posting a change of unch.
TNYA’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TNYA stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.10.
TNYA Stock Stochastic Average
As of today, Tenaya Therapeutics Inc’s raw stochastic average for the last 50 days stands at 88.79%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 86.96%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 90.23% and 86.77%, respectively.
